CN1461020A - 一种制备具有生物相容性的磁性纳米微粒的方法 - Google Patents
一种制备具有生物相容性的磁性纳米微粒的方法 Download PDFInfo
- Publication number
- CN1461020A CN1461020A CN 03136273 CN03136273A CN1461020A CN 1461020 A CN1461020 A CN 1461020A CN 03136273 CN03136273 CN 03136273 CN 03136273 A CN03136273 A CN 03136273A CN 1461020 A CN1461020 A CN 1461020A
- Authority
- CN
- China
- Prior art keywords
- preparation
- polyethylene glycol
- magnetic
- derivative
- nanometer particles
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000005291 magnetic effect Effects 0.000 title claims description 37
- 238000000034 method Methods 0.000 title description 13
- 239000011859 microparticle Substances 0.000 title 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims abstract description 32
- 238000002360 preparation method Methods 0.000 claims abstract description 25
- 229910052742 iron Inorganic materials 0.000 claims abstract description 13
- 239000002122 magnetic nanoparticle Substances 0.000 claims abstract description 10
- 238000010438 heat treatment Methods 0.000 claims abstract description 9
- 239000002798 polar solvent Substances 0.000 claims abstract description 9
- 239000002184 metal Substances 0.000 claims abstract description 8
- 229910052751 metal Inorganic materials 0.000 claims abstract description 8
- 150000002506 iron compounds Chemical class 0.000 claims abstract description 5
- 125000000524 functional group Chemical group 0.000 claims abstract description 3
- 239000002245 particle Substances 0.000 claims description 43
- 239000002202 Polyethylene glycol Substances 0.000 claims description 36
- 229920001223 polyethylene glycol Polymers 0.000 claims description 36
- 235000001014 amino acid Nutrition 0.000 claims description 13
- 229940024606 amino acid Drugs 0.000 claims description 13
- 150000001413 amino acids Chemical class 0.000 claims description 13
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 9
- 238000006243 chemical reaction Methods 0.000 claims description 8
- 229920001577 copolymer Polymers 0.000 claims description 7
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 6
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims description 6
- 235000003704 aspartic acid Nutrition 0.000 claims description 6
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 claims description 6
- 150000001875 compounds Chemical class 0.000 claims description 6
- HNJBEVLQSNELDL-UHFFFAOYSA-N pyrrolidin-2-one Chemical compound O=C1CCCN1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 claims description 6
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 claims description 5
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 claims description 5
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims description 5
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 claims description 5
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 claims description 5
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims description 5
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 claims description 5
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims description 5
- 235000009582 asparagine Nutrition 0.000 claims description 5
- 229960001230 asparagine Drugs 0.000 claims description 5
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims description 5
- 235000018417 cysteine Nutrition 0.000 claims description 5
- 235000013922 glutamic acid Nutrition 0.000 claims description 5
- 239000004220 glutamic acid Substances 0.000 claims description 5
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 claims description 5
- 235000004554 glutamine Nutrition 0.000 claims description 5
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 5
- 239000011553 magnetic fluid Substances 0.000 claims description 5
- 235000004400 serine Nutrition 0.000 claims description 5
- 239000004475 Arginine Substances 0.000 claims description 4
- 125000003368 amide group Chemical group 0.000 claims description 4
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 4
- 238000000354 decomposition reaction Methods 0.000 claims description 4
- 238000001556 precipitation Methods 0.000 claims description 4
- DWNBOPVKNPVNQG-LURJTMIESA-N (2s)-4-hydroxy-2-(propylamino)butanoic acid Chemical compound CCCN[C@H](C(O)=O)CCO DWNBOPVKNPVNQG-LURJTMIESA-N 0.000 claims description 3
- 239000004471 Glycine Substances 0.000 claims description 3
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims description 3
- GDEBSAWXIHEMNF-UHFFFAOYSA-O cupferron Chemical compound [NH4+].O=NN([O-])C1=CC=CC=C1 GDEBSAWXIHEMNF-UHFFFAOYSA-O 0.000 claims description 3
- 125000004185 ester group Chemical group 0.000 claims description 3
- VEPSWGHMGZQCIN-UHFFFAOYSA-H ferric oxalate Chemical compound [Fe+3].[Fe+3].[O-]C(=O)C([O-])=O.[O-]C(=O)C([O-])=O.[O-]C(=O)C([O-])=O VEPSWGHMGZQCIN-UHFFFAOYSA-H 0.000 claims description 3
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 claims description 3
- 229920000747 poly(lactic acid) Polymers 0.000 claims description 3
- 239000004626 polylactic acid Substances 0.000 claims description 3
- PTPLXVHPKMTVIW-FPLPWBNLSA-N (Z)-hydroxyimino-oxido-phenylazanium Chemical compound O\N=[N+](/[O-])c1ccccc1 PTPLXVHPKMTVIW-FPLPWBNLSA-N 0.000 claims description 2
- ZFPGARUNNKGOBB-UHFFFAOYSA-N 1-Ethyl-2-pyrrolidinone Chemical compound CCN1CCCC1=O ZFPGARUNNKGOBB-UHFFFAOYSA-N 0.000 claims description 2
- YEJRWHAVMIAJKC-UHFFFAOYSA-N 4-Butyrolactone Chemical compound O=C1CCCO1 YEJRWHAVMIAJKC-UHFFFAOYSA-N 0.000 claims description 2
- CTZBEEKYUWCPHV-UHFFFAOYSA-N C(C)(=O)C(C(C)=O)C(C)=O.[Fe] Chemical compound C(C)(=O)C(C(C)=O)C(C)=O.[Fe] CTZBEEKYUWCPHV-UHFFFAOYSA-N 0.000 claims description 2
- MFGOTAHWOBKNNU-XMHGGMMESA-N Isodigeranyl Chemical group CC(C)=CCC\C(C)=C\CC(C)(C=C)CCC=C(C)C MFGOTAHWOBKNNU-XMHGGMMESA-N 0.000 claims description 2
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 claims description 2
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims description 2
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 claims description 2
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims description 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims description 2
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims description 2
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims description 2
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims description 2
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 claims description 2
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 claims description 2
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims description 2
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims description 2
- 239000004472 Lysine Substances 0.000 claims description 2
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 claims description 2
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 claims description 2
- 239000004473 Threonine Substances 0.000 claims description 2
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 claims description 2
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims description 2
- 239000002253 acid Substances 0.000 claims description 2
- 229920006243 acrylic copolymer Polymers 0.000 claims description 2
- 235000004279 alanine Nutrition 0.000 claims description 2
- GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 claims description 2
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims description 2
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims description 2
- 229960000310 isoleucine Drugs 0.000 claims description 2
- 229930182817 methionine Natural products 0.000 claims description 2
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims description 2
- 238000000926 separation method Methods 0.000 claims description 2
- 239000004474 valine Substances 0.000 claims description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 2
- 239000000376 reactant Substances 0.000 claims 1
- 230000035484 reaction time Effects 0.000 claims 1
- 239000002105 nanoparticle Substances 0.000 abstract description 5
- 239000000463 material Substances 0.000 abstract description 3
- 229920000151 polyglycol Polymers 0.000 abstract description 3
- 239000010695 polyglycol Substances 0.000 abstract description 3
- 230000004048 modification Effects 0.000 abstract description 2
- 238000012986 modification Methods 0.000 abstract description 2
- SZVJSHCCFOBDDC-UHFFFAOYSA-N ferrosoferric oxide Chemical compound O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 abstract 2
- 238000009835 boiling Methods 0.000 abstract 1
- 230000001376 precipitating effect Effects 0.000 abstract 1
- 229910006297 γ-Fe2O3 Inorganic materials 0.000 abstract 1
- 238000002441 X-ray diffraction Methods 0.000 description 8
- 230000005540 biological transmission Effects 0.000 description 7
- 238000009826 distribution Methods 0.000 description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- 238000010992 reflux Methods 0.000 description 6
- 230000004043 responsiveness Effects 0.000 description 5
- 238000005303 weighing Methods 0.000 description 5
- 239000003814 drug Substances 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 229910001566 austenite Inorganic materials 0.000 description 3
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 2
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 238000003825 pressing Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- LFKXWKGYHQXRQA-FDGPNNRMSA-N (z)-4-hydroxypent-3-en-2-one;iron Chemical compound [Fe].C\C(O)=C\C(C)=O.C\C(O)=C\C(C)=O LFKXWKGYHQXRQA-FDGPNNRMSA-N 0.000 description 1
- ATLYKOUEGIGBCN-UHFFFAOYSA-N 1-ethylpyrrolidin-2-one 1-methylpyrrolidin-2-one Chemical compound C(C)N1C(CCC1)=O.CN1C(CCC1)=O ATLYKOUEGIGBCN-UHFFFAOYSA-N 0.000 description 1
- FYZDLTIEHDHOGL-UHFFFAOYSA-N CC1CCC(=O)O1.C1(CCCO1)=O.CN(P(=O)(N(C)C)N(C)C)C Chemical compound CC1CCC(=O)O1.C1(CCCO1)=O.CN(P(=O)(N(C)C)N(C)C)C FYZDLTIEHDHOGL-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000002429 anti-coagulating effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000000975 co-precipitation Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000005294 ferromagnetic effect Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- LZKLAOYSENRNKR-LNTINUHCSA-N iron;(z)-4-oxoniumylidenepent-2-en-2-olate Chemical compound [Fe].C\C(O)=C\C(C)=O.C\C(O)=C\C(C)=O.C\C(O)=C\C(C)=O LZKLAOYSENRNKR-LNTINUHCSA-N 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000005426 magnetic field effect Effects 0.000 description 1
- 238000003808 methanol extraction Methods 0.000 description 1
- 239000000693 micelle Substances 0.000 description 1
- 239000002405 nuclear magnetic resonance imaging agent Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 229920001308 poly(aminoacid) Polymers 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 150000004040 pyrrolidinones Chemical class 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000010148 water-pollination Effects 0.000 description 1
Images
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y25/00—Nanomagnetism, e.g. magnetoimpedance, anisotropic magnetoresistance, giant magnetoresistance or tunneling magnetoresistance
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01F—MAGNETS; INDUCTANCES; TRANSFORMERS; SELECTION OF MATERIALS FOR THEIR MAGNETIC PROPERTIES
- H01F1/00—Magnets or magnetic bodies characterised by the magnetic materials therefor; Selection of materials for their magnetic properties
- H01F1/01—Magnets or magnetic bodies characterised by the magnetic materials therefor; Selection of materials for their magnetic properties of inorganic materials
- H01F1/03—Magnets or magnetic bodies characterised by the magnetic materials therefor; Selection of materials for their magnetic properties of inorganic materials characterised by their coercivity
- H01F1/12—Magnets or magnetic bodies characterised by the magnetic materials therefor; Selection of materials for their magnetic properties of inorganic materials characterised by their coercivity of soft-magnetic materials
- H01F1/34—Magnets or magnetic bodies characterised by the magnetic materials therefor; Selection of materials for their magnetic properties of inorganic materials characterised by their coercivity of soft-magnetic materials non-metallic substances, e.g. ferrites
- H01F1/342—Oxides
- H01F1/344—Ferrites, e.g. having a cubic spinel structure (X2+O)(Y23+O3), e.g. magnetite Fe3O4
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01F—MAGNETS; INDUCTANCES; TRANSFORMERS; SELECTION OF MATERIALS FOR THEIR MAGNETIC PROPERTIES
- H01F1/00—Magnets or magnetic bodies characterised by the magnetic materials therefor; Selection of materials for their magnetic properties
- H01F1/0036—Magnets or magnetic bodies characterised by the magnetic materials therefor; Selection of materials for their magnetic properties showing low dimensional magnetism, i.e. spin rearrangements due to a restriction of dimensions, e.g. showing giant magnetoresistivity
- H01F1/0045—Zero dimensional, e.g. nanoparticles, soft nanoparticles for medical/biological use
- H01F1/0054—Coated nanoparticles, e.g. nanoparticles coated with organic surfactant
Landscapes
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Nanotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Optics & Photonics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Physics & Mathematics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Crystallography & Structural Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Power Engineering (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Claims (15)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 03136273 CN1219303C (zh) | 2003-05-15 | 2003-05-15 | 一种制备具有生物相容性的磁性纳米微粒的方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 03136273 CN1219303C (zh) | 2003-05-15 | 2003-05-15 | 一种制备具有生物相容性的磁性纳米微粒的方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1461020A true CN1461020A (zh) | 2003-12-10 |
CN1219303C CN1219303C (zh) | 2005-09-14 |
Family
ID=29591299
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 03136273 Expired - Lifetime CN1219303C (zh) | 2003-05-15 | 2003-05-15 | 一种制备具有生物相容性的磁性纳米微粒的方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1219303C (zh) |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007115444A1 (fr) * | 2006-03-31 | 2007-10-18 | Chengdu Kuachang Medical Industrial Limited | Composition de séparation ou d'analyse à nanostructure active et procédé de séparation ou d'analyse |
CN100384415C (zh) * | 2005-01-14 | 2008-04-30 | 上海医药工业研究院 | 一种含有丝裂霉素c的磁性纳米粒的制备方法 |
CN101099931B (zh) * | 2007-05-23 | 2010-05-19 | 江苏天一超细金属粉末有限公司 | 纳米铁系催化剂及其制备方法和装置 |
CN101819838A (zh) * | 2010-03-02 | 2010-09-01 | 中国科学院上海应用物理研究所 | 炔基修饰磁纳米粒子模块、氨基酸类化合物修饰的磁纳米粒子,及制备方法和用途 |
CN101178961B (zh) * | 2006-11-10 | 2011-02-09 | 北京万德高科技发展有限公司 | 高溶解度的水溶磁性纳米晶体及其制备方法 |
CN102265155A (zh) * | 2008-11-10 | 2011-11-30 | 卢米耐克斯公司 | 用于制备和使用多重检测中的大孔珠粒的方法和体系 |
CN101241788B (zh) * | 2007-01-15 | 2012-02-22 | 北京万德高科技发展有限公司 | 在生理缓冲液中能够高度溶解并稳定分散的生物相容性磁性纳米晶体及其制备方法 |
CN102881398A (zh) * | 2012-09-14 | 2013-01-16 | 北京化工大学 | 一种多聚氨基酸包覆的纳米磁流体复合材料及其制备方法 |
CN104388076A (zh) * | 2013-12-26 | 2015-03-04 | 华东理工大学 | 一种水溶性荧光磁小体及其制备方法 |
CN110211758A (zh) * | 2019-06-14 | 2019-09-06 | 南宁师范大学 | 四氧化三铁/金纳米复合颗粒的制备方法 |
-
2003
- 2003-05-15 CN CN 03136273 patent/CN1219303C/zh not_active Expired - Lifetime
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100384415C (zh) * | 2005-01-14 | 2008-04-30 | 上海医药工业研究院 | 一种含有丝裂霉素c的磁性纳米粒的制备方法 |
WO2007115444A1 (fr) * | 2006-03-31 | 2007-10-18 | Chengdu Kuachang Medical Industrial Limited | Composition de séparation ou d'analyse à nanostructure active et procédé de séparation ou d'analyse |
CN101178961B (zh) * | 2006-11-10 | 2011-02-09 | 北京万德高科技发展有限公司 | 高溶解度的水溶磁性纳米晶体及其制备方法 |
CN101241788B (zh) * | 2007-01-15 | 2012-02-22 | 北京万德高科技发展有限公司 | 在生理缓冲液中能够高度溶解并稳定分散的生物相容性磁性纳米晶体及其制备方法 |
CN101099931B (zh) * | 2007-05-23 | 2010-05-19 | 江苏天一超细金属粉末有限公司 | 纳米铁系催化剂及其制备方法和装置 |
CN102265155A (zh) * | 2008-11-10 | 2011-11-30 | 卢米耐克斯公司 | 用于制备和使用多重检测中的大孔珠粒的方法和体系 |
CN102265155B (zh) * | 2008-11-10 | 2014-08-13 | 卢米耐克斯公司 | 用于制备和使用多重检测中的大孔珠粒的方法和体系 |
CN101819838A (zh) * | 2010-03-02 | 2010-09-01 | 中国科学院上海应用物理研究所 | 炔基修饰磁纳米粒子模块、氨基酸类化合物修饰的磁纳米粒子,及制备方法和用途 |
CN102881398A (zh) * | 2012-09-14 | 2013-01-16 | 北京化工大学 | 一种多聚氨基酸包覆的纳米磁流体复合材料及其制备方法 |
CN102881398B (zh) * | 2012-09-14 | 2015-10-14 | 北京化工大学 | 一种多聚氨基酸包覆的纳米磁流体复合材料及其制备方法 |
CN104388076A (zh) * | 2013-12-26 | 2015-03-04 | 华东理工大学 | 一种水溶性荧光磁小体及其制备方法 |
CN110211758A (zh) * | 2019-06-14 | 2019-09-06 | 南宁师范大学 | 四氧化三铁/金纳米复合颗粒的制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN1219303C (zh) | 2005-09-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Sanchez et al. | Polyacrylic acid-coated iron oxide magnetic nanoparticles: The polymer molecular weight influence | |
Nidhin et al. | Synthesis of iron oxide nanoparticles of narrow size distribution on polysaccharide templates | |
Atta et al. | Synthesis of stabilized myrrh-capped hydrocolloidal magnetite nanoparticles | |
CN1461020A (zh) | 一种制备具有生物相容性的磁性纳米微粒的方法 | |
Nalle et al. | Synthesis and characterization of magnetic Fe3O4 nanoparticles using oleic acid as stabilizing agent | |
Nguyen et al. | Templated synthesis of magnetic nanoparticles through the self-assembly of polymers and surfactants | |
CN102344170B (zh) | 用聚酰胺-胺树形分子为模板制备水基Fe3O4磁流体的方法 | |
Jahandar et al. | Synthesis, characterization and application of polyglycerol coated Fe3O4 nanoparticles as a nano-theranostics agent | |
CN106256765B (zh) | 一种磁性羧甲基壳聚糖纳米材料及其制备方法 | |
Salih et al. | Facile synthesis of monodisperse maghemite and ferrite nanocrystals from metal powder and octanoic acid | |
CN101607742A (zh) | 一种水溶性纳米四氧化三铁的制备方法 | |
Sotoma et al. | Monodispersed colloidal solutions of surface-modified detonation-synthesized nanodiamonds and their aggregation resistance | |
CN107224588B (zh) | 一种具有磁-pH值双响应的药物载体的制备方法 | |
Al-Kattan et al. | Purification of biomimetic apatite-based hybrid colloids intended for biomedical applications: A dialysis study | |
Thammawong et al. | Preparation and characterizations of naproxen-loaded magnetic nanoparticles coated with PLA-g-chitosan copolymer | |
CN103127744A (zh) | 一种将油相纳米颗粒转移到水相中的方法 | |
Uchman et al. | CdS-containing nano-assemblies of double hydrophilic block copolymers in water | |
US10154628B2 (en) | Coating metal oxide particles | |
Thanh et al. | Influence of experimental conditions during synthesis on the physicochemical properties of the SPION/hydroxyapatite nanocomposite for magnetic hyperthermia application | |
Başargan et al. | In situ biomimetic synthesis to produce hydroxyapatite–polyvinyl alcohol biocomposites: precipitation and spray drying methods | |
Nesterova et al. | Nanoscale iron (III) oxyhydroxy aggregates formed in the presence of functional water-soluble polymers: models for iron (III) biomineralisation processes | |
CN113845906A (zh) | 一种氮掺杂碳量子点荧光探针的合成及应用 | |
CN104672462A (zh) | 一种增强纳米粒子生物相容性和稳定性的多齿仿生配体及其制备方法 | |
CN109867309B (zh) | 一种水溶磁性氧化铁纳米晶及其制备方法 | |
CN1248249C (zh) | 一种高结晶度的水分散性磁性纳米微粒的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: BEIJING ONEDER HIGHTECH CO. LTD Free format text: FORMER OWNER: INST.OF CHEMISTRY, CHINESE ACADEMY OF SCIENCES Effective date: 20100810 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 000000 NO.2, BEIYI STREET, ZHONGGUANCUN, HAIDIAN DISTRICT, BEIJING CITY TO: 100039 ROOM 265, BUILDING 1, NO.5, DONGCAISHI ROAD, YUQUAN ROAD, HAIDIAN DISTRICT, BEIJING CITY |
|
TR01 | Transfer of patent right |
Effective date of registration: 20100810 Address after: 100039, room 1, building 5, No. 265, East quarry Road, Haidian District, Beijing, Yuquanlu Road Patentee after: BEIJING ONEDER HIGHTECH. Co.,Ltd. Address before: 000000 No. 2 North First Street, Haidian District, Beijing, Zhongguancun Patentee before: Institute of Chemistry, Chinese Academy of Sciences |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20190322 Address after: 215000 Jinjihu Avenue, Suzhou Industrial Park, Northwest of Suzhou Namicheng Patentee after: Suzhou Xin Ying biological medicine technology Co.,Ltd. Address before: Room 265, Building 1, No. 5, East Quarry Road, Yuquan Road, Haidian District, Beijing 100039 Patentee before: BEIJING ONEDER HIGHTECH. Co.,Ltd. |
|
CX01 | Expiry of patent term |
Granted publication date: 20050914 |
|
CX01 | Expiry of patent term |